21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
71.12.Z - Engineering activities and related technical consultancy
71.20.A - Food quality testing and analysis
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,2 | -0 | 93 |
EBITDA | 0,2 | -0 | 0 | 102 |
Short time liabilities | 0,6 | 0,2 | 0,5 | 108 |
Equity capital | 0,6 | 0,4 | 0,3 | -4,8 |
Operating profit (EBIT) | 0 | -0,2 | -0 | 98,6 |
Assets | 1,3 | 0,8 | 1,1 | 32,8 |
Net profit (loss) | -0 | -0,2 | -0 | 93 |
Cash | 0,5 | 0 | 0 | -84,5 |
Net income from sale | 0,8 | 0,8 | 0,8 | 12 |
Liabilities and provisions for liabilities | 0,7 | 0,5 | 0,8 | 62 |
Working assets | 1,1 | 0,8 | 1,1 | 33,9 |
Depreciation | 0,2 | 0,2 | 0 | -97,6 |
% | % | % | p.p. | |
Profitability of capital | -7,1 | -69,1 | -5,1 | 64 |
Equity capital to total assets | 46 | 43,7 | 31,3 | -12,4 |
Gross profit margin | -5,7 | -32,8 | -2,1 | 30,7 |
EBITDA Margin | 24,3 | -6,5 | 0,1 | 6,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 286 | 109 | 203 | 94 |
Current financial liquidity indicator | 1.6526890993118286 | 1.7743897438049316 | 1.456517219543457 | -0,3 |
Net dept to EBITDA | -2.4767022132873535 | 0.4322604537010193 | -7.173863410949707 | -7,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane